Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$37.22 - $100.5 $538,461 - $1.45 Million
-14,467 Reduced 51.65%
13,541 $515,000
Q2 2022

Aug 09, 2022

BUY
$48.99 - $57.46 $1.12 Million - $1.32 Million
22,926 Added 451.12%
28,008 $1.4 Million
Q1 2022

May 17, 2022

BUY
$48.48 - $53.65 $246,375 - $272,649
5,082 New
5,082 $261,000
Q4 2021

Feb 17, 2022

SELL
$47.07 - $52.35 $326,995 - $363,675
-6,947 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$47.89 - $53.12 $332,691 - $369,024
6,947 New
6,947 $335,000
Q4 2020

Feb 24, 2021

SELL
$45.3 - $51.62 $271,075 - $308,894
-5,984 Closed
0 $0
Q3 2020

Dec 11, 2020

SELL
$49.47 - $53.77 $106,508 - $115,766
-2,153 Reduced 26.46%
5,984 $300,000
Q2 2020

Aug 07, 2020

BUY
$42.91 - $52.5 $99,250 - $121,432
2,313 Added 39.71%
8,137 $415,000
Q4 2019

Feb 04, 2020

BUY
$44.25 - $50.86 $257,712 - $296,208
5,824 New
5,824 $292,000
Q2 2019

Aug 13, 2019

SELL
$40.43 - $44.3 $243,186 - $266,464
-6,015 Closed
0 $0
Q1 2019

Apr 12, 2019

SELL
$40.83 - $45.43 $186,756 - $207,796
-4,574 Reduced 43.2%
6,015 $266,000
Q4 2018

Jan 16, 2019

BUY
$41.48 - $45.59 $439,231 - $482,752
10,589 New
10,589 $460,000
Q2 2018

Jul 30, 2018

SELL
$37.63 - $41.22 $311,350 - $341,054
-8,274 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$37.63 - $41.22 $311,350 - $341,054
8,274 New
8,274 $331,000
Q1 2018

May 14, 2018

SELL
$38.98 - $45.76 $764,514 - $897,490
-19,613 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$42.86 - $50.61 $612,083 - $722,761
14,281 Added 267.84%
19,613 $843,000
Q3 2017

Nov 20, 2017

BUY
$47.04 - $50.34 $250,817 - $268,412
5,332
5,332 $265,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $125B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.